A distinct cutaneous reaction to sorafenib and a multikinase inhibitor

Int J Dermatol. 2008 Jul;47(7):767-9. doi: 10.1111/j.1365-4632.2008.03598.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Benzenesulfonates / adverse effects*
  • Benzenesulfonates / therapeutic use
  • Biopsy, Needle
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Head
  • Humans
  • Immunohistochemistry
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / pathology
  • Male
  • Middle Aged
  • Neck
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Protein Kinase Inhibitors / adverse effects*
  • Protein Kinase Inhibitors / therapeutic use
  • Pyridines / adverse effects*
  • Pyridines / therapeutic use
  • Risk Assessment
  • Severity of Illness Index
  • Skin Diseases, Papulosquamous / chemically induced*
  • Skin Diseases, Papulosquamous / drug therapy
  • Skin Diseases, Papulosquamous / pathology
  • Sorafenib
  • Treatment Outcome

Substances

  • Benzenesulfonates
  • Phenylurea Compounds
  • Protein Kinase Inhibitors
  • Pyridines
  • Niacinamide
  • Sorafenib